Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase NA 1Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 141Neoplasms 114Prostatic Neoplasms 59Lung Neoplasms 57Colorectal Neoplasms 52Motor Activity 34Pancreatic Neoplasms 28Uterine Cervical Neoplasms 24Carcinoma, Non-Small-Cell Lung 22Brain Neoplasms 20Head and Neck Neoplasms 19Carcinoma, Hepatocellular 19Rectal Neoplasms 18Ovarian Neoplasms 18Anxiety Disorders 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Disease 15Depression 15Colonic Neoplasms 15Stomach Neoplasms 14Melanoma 14Hematologic Neoplasms 12Lymphoma, Follicular 11Glioblastoma 11Urinary Bladder Neoplasms 10Squamous Cell Carcinoma of Head and Neck 10Smoking Cessation 10Papillomavirus Infections 10Liver Neoplasms 10Leukemia, Myeloid, Acute 10

Interventions

Liquid Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Neuroectodermal Tumors, Primitive, Peripheral × 30 days × Clear all
NCT06068075 2026-05-05

Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD

Dana-Farber Cancer Institute

Phase NA Active not recruiting
340 enrolled
Sarcoma

Sarcoma, Ewing, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡